SEXTANT THERAPEUTICS

Sextant develops groundbreaking cancer therapies from our patented drug discovery technologies developed at MIT. Instead of simply trying to kill the tumor, we have created a way for tumors to dynamically trigger an immune response against cancer, and our technologies help us discover the best drug combinations to prevent relapse. Sextant’s unique pre-clinical drug discovery platform could bring new, more effective chemotherapies to market and save millions of lives.